ClinicalTrials.gov
public full text
Public Domain
Atorvastatin For The Reduction Of Ventricular Arrhythmias
To assess in patients with CAD \[coronary artery disease\] and an implantable defibrillator the effect of atorvastatin 80 mg versus placebo on the first recurrence of a ventricular arrhythmia (ventricular tachycardia or ventricular fibrillation requiring ICD \[implantable cardioverter defibrillator\] intervention) within one year after randomization.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- MUscle Side-Effects of Atorvastatin in Coronary Patients#857342
- Study to Determine if Atorvastatin Reduces Size and Stiffness of Muscle in the Left Ventricle of the Heart#846686
- Statin Therapy In Atrial Refractoriness and Reperfusion Injury#1126134
- Study of Atorvastatin Versus Placebo to Reduce Cardiopulmonary Complications After Thoracic Surgery#1072025
- Acute Rosuvastatin for Preventing Myocardial Damage in Patients With ACS#848211
Record · ID 911017
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive